Therapy optimisation studies in pediatric neurooncology – historical perspectives and future directions
- First Online:
- Cite this article as:
- Benesch, M. memo (2011) 4(Suppl 3): 19. doi:10.1007/s12254-011-0312-1
- 26 Downloads
Risk-adapted treatment stratification is a major characteristic of therapy optimisation studies for the treatment of benign and malignant childhood brain tumours. Thus far a patient having unfavourable risk factors ultimately requires a more intensive treatment in contrast to a patient with a more favourable risk profile. Several neuro-oncological therapy optimisation studies for children with brain tumours were recently initiated for patients with intracranial germ-cell tumours, with relapsed or refractory high-grade gliomas and for standard-risk or low-risk medulloblastoma to include biological parameters. Since our knowledge about the molecular biology of brain tumours is rapidly growing, molecular-based risk stratification will be used also for other brain tumour subtypes in the near future.